Carbapenemase-Producing Enterobacteriaceae Colonization and the Risk of Carbapenemase-Producing Enterobacteriaceae Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Sung-Woon Kang, So Yun Lim, Euijin Chang, Jiwon Jung, Yong Pil Chong, Hyunkyung Park, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Je-Hwan Lee, Sung-Han Kim
{"title":"Carbapenemase-Producing <i>Enterobacteriaceae</i> Colonization and the Risk of Carbapenemase-Producing <i>Enterobacteriaceae</i> Bacteremia in Hematopoietic Stem Cell Transplant Recipients.","authors":"Sung-Woon Kang, So Yun Lim, Euijin Chang, Jiwon Jung, Yong Pil Chong, Hyunkyung Park, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Je-Hwan Lee, Sung-Han Kim","doi":"10.1093/ofid/ofaf516","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Carbapenemase-producing <i>Enterobacteriaceae</i> (CPE) are globally concerning pathogens due to limited therapeutic options. Despite the increasing incidence of CPE infections, evidence supporting effective empirical treatments for individuals undergoing hematopoietic stem cell transplantation (HSCT) remains limited.</p><p><strong>Methods: </strong>From January 2019 to December 2023, individuals undergoing HSCT screened for CPE colonization via perianal swabs upon admission before HSCT were retrospectively analyzed. Culture-based identification and carbapenemase-specific polymerase chain reaction were performed. The occurrence of <i>Enterobacteriaceae</i> bacteremia within 100 days post-HSCT was monitored. Propensity-score (PS) matching and competing risk analyses were used to evaluate the relationship between CPE colonization and bacteremia risk.</p><p><strong>Results: </strong>Among 649 patients undergoing HSCT, 70 (11%) were colonized with CPE. <i>Enterobacteriaceae</i> bacteremia occurred in 20 (29%) CPE-colonized and 56 (10%) noncolonized individuals (<i>P</i> < .001). Among these cases, 17/20 (85%) in the colonized group and 12/56 (21%) in the noncolonized group were caused by CPE (<i>P</i> < .001). After 1:2 PS matching, these rates remained consistent (85% vs 22%, <i>P</i> = .004). All CPE isolates recovered from blood were identical in species and carbapenemase type to those detected in pre-HSCT swabs. Competing risk analyses showed that pre-HSCT CPE colonization was significantly associated with CPE bacteremia (subdistribution hazard ratio [sHR] 13.1, 95% confidence interval [CI] 6.27-27.3, <i>P</i> < .001; after matching: sHR 19.1, 95% CI 4.42-82.20, <i>P</i> < .001).</p><p><strong>Conclusions: </strong>Pre-HSCT CPE colonization increases <i>Enterobacteriaceae</i> bacteremia risk. Routine screening and empirical CPE-directed therapy are essential to improving clinical outcomes.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"12 9","pages":"ofaf516"},"PeriodicalIF":3.8000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12418090/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Forum Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ofid/ofaf516","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are globally concerning pathogens due to limited therapeutic options. Despite the increasing incidence of CPE infections, evidence supporting effective empirical treatments for individuals undergoing hematopoietic stem cell transplantation (HSCT) remains limited.
Methods: From January 2019 to December 2023, individuals undergoing HSCT screened for CPE colonization via perianal swabs upon admission before HSCT were retrospectively analyzed. Culture-based identification and carbapenemase-specific polymerase chain reaction were performed. The occurrence of Enterobacteriaceae bacteremia within 100 days post-HSCT was monitored. Propensity-score (PS) matching and competing risk analyses were used to evaluate the relationship between CPE colonization and bacteremia risk.
Results: Among 649 patients undergoing HSCT, 70 (11%) were colonized with CPE. Enterobacteriaceae bacteremia occurred in 20 (29%) CPE-colonized and 56 (10%) noncolonized individuals (P < .001). Among these cases, 17/20 (85%) in the colonized group and 12/56 (21%) in the noncolonized group were caused by CPE (P < .001). After 1:2 PS matching, these rates remained consistent (85% vs 22%, P = .004). All CPE isolates recovered from blood were identical in species and carbapenemase type to those detected in pre-HSCT swabs. Competing risk analyses showed that pre-HSCT CPE colonization was significantly associated with CPE bacteremia (subdistribution hazard ratio [sHR] 13.1, 95% confidence interval [CI] 6.27-27.3, P < .001; after matching: sHR 19.1, 95% CI 4.42-82.20, P < .001).
Conclusions: Pre-HSCT CPE colonization increases Enterobacteriaceae bacteremia risk. Routine screening and empirical CPE-directed therapy are essential to improving clinical outcomes.
期刊介绍：
Open Forum Infectious Diseases provides a global forum for the publication of clinical, translational, and basic research findings in a fully open access, online journal environment. The journal reflects the broad diversity of the field of infectious diseases, and focuses on the intersection of biomedical science and clinical practice, with a particular emphasis on knowledge that holds the potential to improve patient care in populations around the world. Fully peer-reviewed, OFID supports the international community of infectious diseases experts by providing a venue for articles that further the understanding of all aspects of infectious diseases.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
